BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 4604574)

  • 1. Immunotherapy of coccidioidomycosis.
    Catanzaro A; Spitler L; Moser KM
    J Clin Invest; 1974 Sep; 54(3):690-701. PubMed ID: 4604574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro lymphocyte responses of coccidioidin skin test-positive and -negative persons to coccidioidin, spherulin, and a coccidioides cell wall antigen.
    Cox RA; Brummer E; Lecara G
    Infect Immun; 1977 Mar; 15(3):751-5. PubMed ID: 870430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular immune response in coccidioidomycosis.
    Catanzaro A; Spitler LE; Moser KM
    Cell Immunol; 1975 Feb; 15(2):360-71. PubMed ID: 1089482
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo and in vitro cell-mediated responses in coccidioidomycosis. I. Immumologic responses of persons with primary, asymptomatic infections.
    Cox RA; Vivas JR; Gross A; Lecara G; Miller E; Brummer E
    Am Rev Respir Dis; 1976 Nov; 114(5):937-43. PubMed ID: 791035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of transfer factor on lymphocyte function in anergic patients.
    Kirkpatrick CH; Rich RR; Smith TK
    J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons of mycelia- and spherule-derived antigens in cellular immune assays of Coccidioides immitis-infected guinea pigs.
    Cox RA; Mead CG; Pavey EF
    Infect Immun; 1981 Feb; 31(2):687-92. PubMed ID: 7012017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro assays of cellular immunity in progressive coccidioidomycosis: evaluation of suppression with parasitic-phase antigen.
    Harvey RP; Stevens DA
    Am Rev Respir Dis; 1981 Jun; 123(6):665-9. PubMed ID: 7271066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy in recurrent coccidioidomycosis.
    Stevens DA; Pappagianis D; Marinkovich VA; Waddell TF
    Cell Immunol; 1974 Apr; 12(1):37-48. PubMed ID: 4458962
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunotherapy of coccidiomycosis].
    Graybill JR
    Bull Int Union Tuberc; 1976; 51(1 Pt 2):529-33. PubMed ID: 802716
    [No Abstract]   [Full Text] [Related]  

  • 10. Parameters of T cell mediated immunity to commensal micro-organisms in patients with chronic purulent rhinosinusitis: a comparison between delayed type hypersensitivity skin test, lymphocyte transformation test and macrophage migration inhibition factor assay.
    van de Plassche-Boers EM; Drexhage HA; Kokjé-Kleingeld M; Leezenberg HA
    Clin Exp Immunol; 1986 Dec; 66(3):516-24. PubMed ID: 3552334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro assessment of cellular immunity in human coccidioidomycosis: relationship between dermal hypersensitivity, lymphocyte transformation, and lymphokine production by peripheral blood mononuclear cells from healthy adults.
    Ampel NM; Bejarano GC; Salas SD; Galgiani JN
    J Infect Dis; 1992 Apr; 165(4):710-5. PubMed ID: 1552200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by cell wall antigens of Coccidioides immitis.
    Cox RA
    Rev Infect Dis; 1988; 10 Suppl 2():S415-8. PubMed ID: 3263691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous sensitivity and in vitro responsiveness of lymphocytes in patients with disseminated coccidioidomycosis.
    Opelz G; Scheer MI
    J Infect Dis; 1975 Sep; 132(3):250-5. PubMed ID: 1159328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis.
    Ampel NM; Nelson DK; Chavez S; Naus KA; Herman AB; Li L; Simmons KA; Pappagianis D
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):700-4. PubMed ID: 15939743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of coccidioidal anergy in vitro by dendritic cells from patients with disseminated coccidioidomycosis.
    Richards JO; Ampel NM; Lake DF
    J Immunol; 2002 Aug; 169(4):2020-5. PubMed ID: 12165528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular immunity in patients with the Wiskott-Aldrich syndrome before and after administration of transfer factor: a follow-up study.
    Schut BJ; Dooren LJ; Uittenbogaart CH; Schellekens PT; Eijsvoogel VP
    Immunology; 1979 Jan; 36(1):1-12. PubMed ID: 369991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis.
    Cox RA; Pope RM
    Infect Immun; 1987 May; 55(5):1058-62. PubMed ID: 3552984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coccidioidomycosis: early immunologic findings.
    Miller CH; MacKenzie MR; Paglieroni T; Goldstein E
    West J Med; 1983 Jan; 138(1):55-9. PubMed ID: 6601331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum.
    Newberry WM; Sanford JP
    J Clin Invest; 1971 Jun; 50(6):1262-71. PubMed ID: 5578233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The present status of vaccination against coccidioidomycosis in man.
    Pappagianis D; Levine HB
    Am J Epidemiol; 1975 Jul; 102(1):30-41. PubMed ID: 1155435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.